Research
Hormonal
Klinefelter syndrome is associated with a significantly increased risk of metabolic syndrome, type 2 diabetes, and abdominal adiposity, independent of some socioeconomic factors.
Men with Klinefelter syndrome have a much higher risk of metabolic syndrome and diabetes than the general population. Regular screening for blood sugar, lipids, and waist circumference is essential, even if weight appears normal, due to the tendency for abdominal fat accumulation.
GoodSupportsHIGH confidence
Almost half of the KS patients fulfilled criteria for the metabolic syndrome, whereas it was true for only 10% of the control group... Type 2 diabetes is frequent in hypogonadal patients... hypogonadism is also more prevalent among type 2 diabetics
Why this rating
Based on large cohort studies (British and Danish) with consistent findings across multiple papers cited.
Source
Klinefelter Syndrome—A Clinical Update
Kristian A. Groth et al. · The Journal of Clinical Endocrinology & Metabolism · 2012
DOI 10.1210/jc.2012-2382
narrative_reviewCited 488×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →